Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS‐CoV‐2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage
Juan Ma, Fangrui Zhu, Min Zhao, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 494
Innate immunological pathways in COVID-19 pathogenesis
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 157
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
Lieselotte Vande Walle, Mohamed Lamkanfi
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 43-66
Closed Access | Times Cited: 102
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
SARS-CoV-2 and the Host Cell: A Tale of Interactions
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, et al.
Frontiers in Virology (2022) Vol. 1
Open Access | Times Cited: 69
Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors
Zhen Dai, Wan-Cong Liu, Xiaoyi Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
The gasdermin family: emerging therapeutic targets in diseases
Cheng‐long Zhu, Sheng Xu, Ruoyu Jiang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Inflammasome Activation by RNA Respiratory Viruses: Mechanisms, Viral Manipulation, and Therapeutic Insights
Tamara Silva Rodrigues, Dario S. Zamboni
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein
Mustafa Yalcınkaya, Wenli Liu, Mohammad Naimul Islam, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 68
Phloem iron remodels root development in response to ammonium as the major nitrogen source
Xing Xing Liu, Hai Hua Zhang, Qing Yang Zhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 63
Viral manipulation of host cell necroptosis and pyroptosis
Simon Verdonck, Josephine Nemegeer, Peter Vandenabeele, et al.
Trends in Microbiology (2021) Vol. 30, Iss. 6, pp. 593-605
Open Access | Times Cited: 58
Viral-mediated activation and inhibition of programmed cell death
Shayla Grace Verburg, Rebecca Margaret Lelievre, Michael J. Westerveld, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 8, pp. e1010718-e1010718
Open Access | Times Cited: 52
Programmed cell death: the pathways to severe COVID-19?
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 49
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis
Mostafa Eltobgy, Ashley Zani, Adam D. Kenney, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 46
Coronaviruses Nsp5 Antagonizes Porcine Gasdermin D-Mediated Pyroptosis by Cleaving Pore-Forming p30 Fragment
Fushan Shi, Qian Lv, Tingjun Wang, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
The role of cell death in SARS-CoV-2 infection
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
A cytomegalovirus inflammasome inhibitor reduces proinflammatory cytokine release and pyroptosis
Y. Deng, Eléonore Ostermann, Wolfram Brune
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
Debashis Dutta, Jianuo Liu, Huangui Xiong
PubMed (2022) Vol. 14, Iss. 3, pp. 138-160
Closed Access | Times Cited: 32
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
Haiyun Yu, Fei Guan, Heather Miller, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19
Man Wang, Wenguang Chang, Lei Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5827-5848
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top